logo

$5 And Under

Share SHARE

Marinus Pharmaceuticals (MRNS) has been climbing for the majority of early trade Monday and is currently higher by 0.68 at $3.10 on above average volume. Marinus Pharmaceuticals has been on an upward trend for the past month and has surged to a new high for the year.

Zynerba Pharmaceuticals Inc. (ZYNE) announced Monday morning that its Phase 2 study of ZYN002 in patients with Osteoarthritis did not meet its primary endpoint. Zynerba Pharmaceuticals gapped open sharply lower this morning and has continued to lose ground in early trade. Shares are now down 1.42...

J. C. Penney (JCP) reported a second quarter adjusted loss of $0.09 per share Friday morning, compared to the loss of $0.05 per share last year. Analysts expected a loss of $0.05 per share. J. C. Penney gapped open sharply lower Friday, but traded in a range for the bulk of the session. Shares of...

Black Box Corp. (BBOX) reported a first quarter loss of $0.33 per share after the close Thursday, compared to the profit of $0.13 per share last year. Analysts expected EPS of $0.01. Black Box gapped open sharply lower Friday and declined during the first half hour of trade. The stock finished down...

Black Box Corp. (BBOX) reported a first quarter loss of $0.33 per share after the close Thursday, compared to the profit of $0.13 per share last year. Analysts expected EPS of $0.01. Black Box gapped open sharply lower Friday and has continued to decline in early trade. The stock is now down 2.75...

J. C. Penney (JCP) reported a second quarter adjusted loss of $0.09 per share Friday morning, compared to the loss of $0.05 per share last year. Analysts expected a loss of $0.05 per share. J. C. Penney gapped open sharply lower this morning and is now down 0.71 at $4.00 on above average volume. The...

Babcock & Wilcox Enterprises (BW) reported a second quarter loss of $2.63 per share after the bell Wednesday, compared to the loss of $0.20 per share last year. The consensus estimate was for a profit of $0.06 per share. Babcock & Wilcox Enterprises gapped open sharply lower Thursday and declined...

TearLab Corp. (TEAR) has been rising sharply since the open of trade Friday. The stock is now up 1.38 at $3.14 on the highest volume of the year. TearLab has broken out of a narrow range at the lows of the year and has set over a 2-month high.

CymaBay Therapeutics Inc. (CBAY) reported positive results from its Phase 2 study of seladelpar in patients with primary biliary cholangitis Monday morning. CymaBay Therapeutics gapped open sharply higher this morning and is now up 1.70 at $7.35 with volume at over a 6-month high. The stock has broken...

Follow RTT